Related Experiment Videos
High-density lipoprotein cholesterol and treatment guidelines
1Department of Cardiology, Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia. ton@austin.unimelb.edu.au
The American Journal of Cardiology
|January 15, 2002
Summary
New guidelines are emerging to manage high-density lipoprotein cholesterol (HDL-C) levels. Incorporating HDL-C targets improves cardiovascular outcomes, especially for high-risk patients.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Clinical Guideline Development
Background:
- Lipid management guidelines often lack precision and practicality.
- High-density lipoprotein cholesterol (HDL-C) has been historically underutilized as a cardiovascular risk predictor and therapeutic target.
- Recent research highlights HDL-C's role in atherosclerotic disease pathophysiology.
Purpose of the Study:
- To advocate for the incorporation of HDL-C into clinical guidelines.
- To establish clear threshold and target levels for HDL-C management.
- To improve cardiovascular outcomes through practical guideline implementation.
Main Methods:
- Review of current lipid management guidelines.
- Analysis of recent clinical trial data on HDL-C.
- Consideration of factors balancing specialist precision and general practitioner practicality.
Main Results:
- Growing recognition of HDL-C's significance in cardiovascular risk.
- Clinical trial evidence supports increasing low HDL-C levels to reduce cardiovascular events.
- Guidelines incorporating HDL-C targets offer a practical approach to patient management.
Conclusions:
- Consistent lipid management guidelines require balancing precision and practicality.
- HDL-C should be integrated into guidelines as a key therapeutic target.
- Managing HDL-C levels in high-risk populations, including the elderly and those with type 2 diabetes, can improve patient outcomes.